No related posts.


The Year in Review: Top Ten Michael Geist Substacks
The Year in Review: Top Ten Law Bytes Podcast Episodes
The Year in Review: Top Ten Posts
The Law Bytes Podcast, Episode 254: Looking Back at the Year in Canadian Digital Law and Policy
Confronting Antisemitism in Canada: If Leaders Won’t Call It Out Without Qualifiers, They Can’t Address It
Michael Geist
mgeist@uottawa.ca
This web site is licensed under a Creative Commons License, although certain works referenced herein may be separately licensed.
deliberately adding cost to health care
is precisely why Canada should not enter into this agreement. Also, the lack of transparency in the deal is troubling. Just whom, other multinational pharmaceutical companies and myopic French farmers, is this agreement benefiting? Why would we enter such a costly agreement especially when both federal and provincial levels of government are running large deficits? The government needs to answer those question directly.